Thephaco: Constantly innovating to affirm its position in the market

Established in May 1961, Thephaco Pharmaceutical Medical Materials Company (Thephaco) is a unit with long experience in providing health products and services.

Faced with competitive pressure from new businesses with high sensitivity to technology, Thephaco’s leadership has actively invested in renovating equipment, developing markets, building quality management apparatus to avoid falling behind and affirm the Company’s position before competitors in the same industry.

After investing nearly VND 50 billion to purchase machinery and install complete production lines, Thephaco’s modern machinery system has met most of the current pharmaceutical industry requirements. Blactam line is invested and renovated into 2 production lines of Penicillin and Cephalosporin; at the same time, installing and putting into use the production line of health protection food in the form of effervescent tablets, soft capsules, oral ampoules, bottled water. These lines have significantly improved the company’s labor productivity, helped the company save human resources, reduce error rates and improve productivity.

Currently, the company is operating 02 factories producing western medicine and traditional medicines that meet GMP-WHO standards, 01 factories producing health-protecting foods meeting GMP-HS standards. Most production processes are automated, minimizing the labor force. Control cameras are installed at every production line, so that production processes are thoroughly monitored and monitored, minimizing unnecessary errors.

In addition, Thephaco also focuses on researching, cooperating with scientists, deploying many scientific topics, creating new products that are valuable and highly effective from the inherent pharmaceutical resources of our country. Among them are: Clathepham, Soluthepham, Biofil 10ml glass vial, Biote electrolyte rehydration water, Trang Vi Thanh, Minh Nao Thanh, etc. The company has been trying to improve further to advance by 2025 with a factory meeting GMP-EU standards.

Thephaco also focuses on expanding drug distribution channels (DMS), supporting the establishment of agents, with the purpose of promoting, introducing and marketing products to consumers across the country. In addition, the Company has also applied software solutions to modernize the way of managing the pharmaceutical distribution system. As a result, a nationwide distribution system with 15,800 drugstores and drugstores provided products manufactured by the company. In 2019, sales of goods via DMS channel will reach VND 58.8 billion (accounting for 14.7% of the revenue of manufacturing companies), and it is expected to reach VND 83 billion by 2020.

For the management apparatus, the company management hired Indian experts to rebuild the SOP system (standard operating procedure), improve training for workers; building a new working rule towards professionalism, modernism, associating interests and responsibilities with work efficiency, creating a dynamic, creative working environment, ensuring democracy and solidarity throughout the company. In the factory area, renovating the Non blactam factory into a Penicillin and Cephalosporin drug factory, etc.

With the steadfastness in the renovation plan, along with careful preparation and dedication from people in the investment in equipment and technology innovation, Thephaco has achieved very satisfactory results. By the end of 2019, the Company’s production volume reached VND 404 billion, an increase of 32.89% compared to 2018; contributed 14.85 billion VND to the State budget, an increase of 16.34% compared to 2018. The average income of employees reached over 6 million VND/month, especially many workers reached a salary of over 10 million VND/month.

In the coming time, Thephaco will constantly innovate and will certainly make further strides in the pharmaceutical market, worthy of the Labor Hero title that the State has awarded.

Productivity and Quality Office